Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR Ex20ins NSCLC

Four chemo cycles given with durvalumab and tremelimumab optimise response and tumour shrinkage in patients with mNSCLC

LUMINANCE: Results support use of durvalumab and platinum-etoposide for extensive stage SCLC

CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for patients with pretreated, KRASG12C-mutated advanced NSCLC

Latest treatments in oesophageal cancer

Final data from phase II study of eftilagimod alpha and pembro in PD-1/PD-L1 inhibitors resistant second line metastatic NSCLC

Neo-adjuvant therapy for different cancers in the Philippines

The pros and cons of breast IORT and ultra hypofractionation (FR)

War in Ukraine: The logistical challenges of transferring medical materials

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer

Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PC

Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti-tumour activity